- Home
- BCLI vs MSN Comparison
BCLI vs MSN Comparison
Compare BCLI & MSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- MSN
- Stock Information
- Founded
- BCLI 2000
- MSN 1948
- Country
- BCLI United States
- MSN United States
- Employees
- BCLI N/A
- MSN N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- MSN Consumer Electronics/Appliances
- Sector
- BCLI Health Care
- MSN Consumer Staples
- Exchange
- BCLI Nasdaq
- MSN Nasdaq
- Market Cap
- BCLI 9.8M
- MSN 8.6M
- IPO Year
- BCLI N/A
- MSN 1994
- Fundamental
- Price
- BCLI $1.08
- MSN $0.39
- Analyst Decision
- BCLI Strong Buy
- MSN
- Analyst Count
- BCLI 1
- MSN 0
- Target Price
- BCLI $30.00
- MSN N/A
- AVG Volume (30 Days)
- BCLI 473.4K
- MSN 15.0K
- Earning Date
- BCLI 08-13-2025
- MSN 08-13-2025
- Dividend Yield
- BCLI N/A
- MSN N/A
- EPS Growth
- BCLI N/A
- MSN N/A
- EPS
- BCLI N/A
- MSN N/A
- Revenue
- BCLI N/A
- MSN $11,140,000.00
- Revenue This Year
- BCLI N/A
- MSN N/A
- Revenue Next Year
- BCLI N/A
- MSN N/A
- P/E Ratio
- BCLI N/A
- MSN N/A
- Revenue Growth
- BCLI N/A
- MSN 27.46
- 52 Week Low
- BCLI $0.72
- MSN $0.35
- 52 Week High
- BCLI $6.45
- MSN $0.83
- Technical
- Relative Strength Index (RSI)
- BCLI 43.20
- MSN 42.00
- Support Level
- BCLI $1.08
- MSN $0.41
- Resistance Level
- BCLI $1.32
- MSN $0.42
- Average True Range (ATR)
- BCLI 0.10
- MSN 0.03
- MACD
- BCLI -0.01
- MSN -0.00
- Stochastic Oscillator
- BCLI 4.00
- MSN 7.86
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About MSN Emerson Radio Corporation
Emerson Radio Corp operates in the consumer electronics industry. The company designs, sources, imports, and markets a variety of houseware and consumer electronic products, and licenses the Emerson trademark domestically and internationally. Its products are offered to encompass televisions, digital versatile disc players and video cassette recorders, audio accessories, microwave ovens, home theatres, high-end audio products, office products, mobile stereo, and wireless products. geographically, it derives a majority of its revenue from the United States.